{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:33:34Z","timestamp":1774935214429,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20354"],"award-info":[{"award-number":["U22A20354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11892-8","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T03:03:06Z","timestamp":1753930986000},"page":"889-900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gray matter sodium accumulation and atrophy in relapsing-remitting multiple sclerosis correspond to neurotransmitter maps"],"prefix":"10.1007","volume":"36","author":[{"given":"Yan","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaolong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6252-9450","authenticated-orcid":false,"given":"Wenzhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"11892_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"11892_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.748357","volume":"12","author":"A Radetz","year":"2021","unstructured":"Radetz A, Mladenova K, Ciolac D et al (2021) Linking microstructural integrity and motor cortex excitability in multiple sclerosis. Front Immunol 12:748357","journal-title":"Front Immunol"},{"key":"11892_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1148\/radiol.2018180719","volume":"288","author":"R Zivadinov","year":"2018","unstructured":"Zivadinov R (2018) Why is cognitive impairment present in multiple sclerosis? Insights from functional MRI. Radiology 288:552\u2013553","journal-title":"Radiology"},{"key":"11892_CR4","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/brain\/awy088","volume":"141","author":"A Eshaghi","year":"2018","unstructured":"Eshaghi A, Marinescu RV, Young AL et al (2018) Progression of regional grey matter atrophy in multiple sclerosis. Brain 141:1665\u20131677","journal-title":"Brain"},{"key":"11892_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/brain\/awv337","volume":"139","author":"MD Steenwijk","year":"2016","unstructured":"Steenwijk MD, Geurts JJ, Daams M et al (2016) Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. Brain 139:115\u2013126","journal-title":"Brain"},{"key":"11892_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1148\/radiol.14132708","volume":"272","author":"MD Steenwijk","year":"2014","unstructured":"Steenwijk MD, Daams M, Pouwels PJ et al (2014) What explains gray matter atrophy in long-standing multiple sclerosis? Radiology 272:832\u2013842","journal-title":"Radiology"},{"key":"11892_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamaneurol.2022.1025","volume":"79","author":"A Cagol","year":"2022","unstructured":"Cagol A, Schaedelin S, Barakovic M et al (2022) Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis. JAMA Neurol 79:682\u2013692","journal-title":"JAMA Neurol"},{"key":"11892_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrn2023","volume":"7","author":"SG Waxman","year":"2006","unstructured":"Waxman SG (2006) Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci 7:932\u2013941","journal-title":"Nat Rev Neurosci"},{"key":"11892_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/brain\/awab043","volume":"144","author":"S Collorone","year":"2021","unstructured":"Collorone S, Prados F, Kanber B et al (2021) Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event. Brain 144:1409\u20131421","journal-title":"Brain"},{"key":"11892_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11060-023-04363-x","volume":"163","author":"NS Cho","year":"2023","unstructured":"Cho NS, Sanvito F, Thakuria S et al (2023) Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas. J Neurooncol 163:417\u2013427","journal-title":"J Neurooncol"},{"key":"11892_CR11","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/alz.12501","volume":"17","author":"A Haeger","year":"2021","unstructured":"Haeger A, Bottlaender M, Lagarde J et al (2021) What can 7T sodium MRI tell us about cellular energy depletion and neurotransmission in Alzheimer\u2019s disease? Alzheimers Dement 17:1843\u20131854","journal-title":"Alzheimers Dement"},{"key":"11892_CR12","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/brain\/awp334","volume":"133","author":"M Inglese","year":"2010","unstructured":"Inglese M, Madelin G, Oesingmann N et al (2010) Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 Tesla. Brain 133:847\u2013857","journal-title":"Brain"},{"key":"11892_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiol.12112680","volume":"264","author":"W Zaaraoui","year":"2012","unstructured":"Zaaraoui W, Konstandin S, Audoin B et al (2012) Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study. Radiology 264:859\u2013867","journal-title":"Radiology"},{"key":"11892_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.mito.2010.05.014","volume":"10","author":"ME Witte","year":"2010","unstructured":"Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J (2010) Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration? Mitochondrion 10:411\u2013418","journal-title":"Mitochondrion"},{"key":"11892_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1212\/WNL.0000000000003511","volume":"88","author":"A Maarouf","year":"2017","unstructured":"Maarouf A, Audoin B, Pariollaud F et al (2017) Increased total sodium concentration in gray matter better explains cognition than atrophy in MS. Neurology 88:289\u2013295","journal-title":"Neurology"},{"key":"11892_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10334-013-0396-1","volume":"27","author":"A Maarouf","year":"2014","unstructured":"Maarouf A, Audoin B, Konstandin S et al (2014) Topography of brain sodium accumulation in progressive multiple sclerosis. MAGMA 27:53\u201362","journal-title":"MAGMA"},{"key":"11892_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109610","volume":"137","author":"J Arm","year":"2021","unstructured":"Arm J, Oeltzschner G, Al-Iedani O, Lea R, Lechner-Scott J, Ramadan S (2021) Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue. Eur J Radiol 137:109610","journal-title":"Eur J Radiol"},{"key":"11892_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cnp.2019.01.004","volume":"4","author":"R Lazo-Gomez","year":"2019","unstructured":"Lazo-Gomez R, Vel\u00e1zquez GLL, Mireles-Jacobo D, Sotomayor-Sobrino MA (2019) Mechanisms of neurobehavioral abnormalities in multiple sclerosis: contributions from neural and immune components. Clin Neurophysiol Pract 4:39\u201346","journal-title":"Clin Neurophysiol Pract"},{"key":"11892_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jad.2023.02.146","volume":"329","author":"Y Liu","year":"2023","unstructured":"Liu Y, Sun J, Jiang J et al (2023) Brain functional specialization in obsessive-compulsive disorder associated with neurotransmitter profiles. J Affect Disord 329:477\u2013482","journal-title":"J Affect Disord"},{"key":"11892_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hbm.25244","volume":"42","author":"J Dukart","year":"2021","unstructured":"Dukart J, Holiga S, Rullmann M et al (2021) JuSpace: a tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Hum Brain Mapp 42:555\u2013566","journal-title":"Hum Brain Mapp"},{"key":"11892_CR21","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41380-023-01943-1","volume":"28","author":"A Fiore","year":"2023","unstructured":"Fiore A, Preziosa P, Tedone N et al (2023) Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis. Molecular Psychiatry 28:1770\u20131782","journal-title":"Molecular Psychiatry"},{"key":"11892_CR22","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/hbm.21344","volume":"33","author":"M Battaglini","year":"2012","unstructured":"Battaglini M, Jenkinson M, De Stefano N (2012) Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 33:2062\u20132071","journal-title":"Hum Brain Mapp"},{"key":"11892_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/brain\/awv386","volume":"139","author":"M Petracca","year":"2016","unstructured":"Petracca M, Vancea RO, Fleysher L, Jonkman LE, Oesingmann N, Inglese M (2016) Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study. Brain 139:795\u2013806","journal-title":"Brain"},{"key":"11892_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuroimage.2012.07.001","volume":"63","author":"M Savli","year":"2012","unstructured":"Savli M, Bauer A, Mitterhauser M et al (2012) Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage 63:447\u2013459","journal-title":"Neuroimage"},{"key":"11892_CR25","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/jcbfm.2015.53","volume":"35","author":"K Alakurtti","year":"2015","unstructured":"Alakurtti K, Johansson JJ, Joutsa J et al (2015) Long-term test-retest reliability of striatal and extrastriatal dopamine D2\/3 receptor binding: study with [(11)C]raclopride and high-resolution PET. J Cereb Blood Flow Metab 35:1199\u20131205","journal-title":"J Cereb Blood Flow Metab"},{"key":"11892_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22444-0","volume":"8","author":"J Dukart","year":"2018","unstructured":"Dukart J, Holiga \u0160, Chatham C et al (2018) Cerebral blood flow predicts differential neurotransmitter activity. Sci Rep 8:4074","journal-title":"Sci Rep"},{"key":"11892_CR27","first-page":"350","volume":"32","author":"FJ Garc\u00eda-G\u00f3mez","year":"2013","unstructured":"Garc\u00eda-G\u00f3mez FJ, Garc\u00eda-Sol\u00eds D, Luis-Sim\u00f3n FJ et al (2013) [Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane]. Rev Esp Med Nucl Imagen Mol 32:350\u2013356","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"11892_CR28","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s00259-016-3590-3","volume":"44","author":"S Hesse","year":"2017","unstructured":"Hesse S, Becker GA, Rullmann M et al (2017) Central noradrenaline transporter availability in highly obese, non-depressed individuals. Eur J Nucl Med Mol Imaging 44:1056\u20131064","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11892_CR29","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00259-017-3645-0","volume":"44","author":"S Kaller","year":"2017","unstructured":"Kaller S, Rullmann M, Patt M et al (2017) Test-retest measurements of dopamine D(1)-type receptors using simultaneous PET\/MRI imaging. Eur J Nucl Med Mol Imaging 44:1025\u20131032","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11892_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ana.25145","volume":"83","author":"A Eshaghi","year":"2018","unstructured":"Eshaghi A, Prados F, Brownlee WJ et al (2018) Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann Neurol 83:210\u2013222","journal-title":"Ann Neurol"},{"key":"11892_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.22109","volume":"69","author":"GR Campbell","year":"2011","unstructured":"Campbell GR, Ziabreva I, Reeve AK et al (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481\u2013492","journal-title":"Ann Neurol"},{"key":"11892_CR32","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/brain\/awt110","volume":"136","author":"MT Fischer","year":"2013","unstructured":"Fischer MT, Wimmer I, H\u00f6ftberger R et al (2013) Disease-specific molecular events in cortical multiple sclerosis lesions. Brain 136:1799\u20131815","journal-title":"Brain"},{"key":"11892_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/brain\/awt324","volume":"137","author":"S Al-Izki","year":"2014","unstructured":"Al-Izki S, Pryce G, Hankey DJ et al (2014) Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis. Brain 137:92\u2013108","journal-title":"Brain"},{"key":"11892_CR34","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1152\/jn.00434.2003","volume":"90","author":"AC Lo","year":"2003","unstructured":"Lo AC, Saab CY, Black JA, Waxman SG (2003) Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 90:3566\u20133571","journal-title":"J Neurophysiol"},{"key":"11892_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/acschemneuro.2c00589","volume":"14","author":"E Akyuz","year":"2023","unstructured":"Akyuz E, Celik BR, Aslan FS, Sahin H, Angelopoulou E (2023) Exploring the role of neurotransmitters in multiple sclerosis: an expanded review. ACS Chem Neurosci 14:527\u2013553","journal-title":"ACS Chem Neurosci"},{"key":"11892_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369","journal-title":"Nat Rev Neurosci"},{"key":"11892_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/brain\/awq362","volume":"134","author":"PE Polak","year":"2011","unstructured":"Polak PE, Kalinin S, Feinstein DL (2011) Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 134:665\u2013677","journal-title":"Brain"},{"key":"11892_CR38","doi-asserted-by":"crossref","unstructured":"Gatta V, Mengod G, Reale M, Tata AM (2020) Possible correlation between cholinergic system alterations and neuro\/inflammation in multiple sclerosis. Biomedicines 8:153","DOI":"10.3390\/biomedicines8060153"},{"key":"11892_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jns.2018.06.020","volume":"392","author":"CRN Polachini","year":"2018","unstructured":"Polachini CRN, Spanevello RM, Schetinger MRC, Morsch VM (2018) Cholinergic and purinergic systems: A key to multiple sclerosis? J Neurol Sci 392:8\u201321","journal-title":"J Neurol Sci"},{"key":"11892_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jneuroim.2018.01.016","volume":"318","author":"C Liu","year":"2018","unstructured":"Liu C, Liu H, Jin H, Yue X, Luo Z, Tu Z (2018) Cholinergic imbalance in lumbar spinal cord of a rat model of multiple sclerosis. J Neuroimmunol 318:29\u201335","journal-title":"J Neuroimmunol"},{"key":"11892_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0163-7258(01)00158-9","volume":"92","author":"NR Zahniser","year":"2001","unstructured":"Zahniser NR, Doolen S (2001) Chronic and acute regulation of Na+\/Cl\u2013dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92:21\u201355","journal-title":"Pharmacol Ther"},{"key":"11892_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00259-013-2636-z","volume":"41","author":"S Hesse","year":"2014","unstructured":"Hesse S, Moeller F, Petroff D et al (2014) Altered serotonin transporter availability in patients with multiple sclerosis. Eur J Nucl Med Mol Imaging 41:827\u2013835","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11892_CR43","doi-asserted-by":"publisher","first-page":"68s","DOI":"10.2967\/jnumed.121.263202","volume":"63","author":"H Barthel","year":"2022","unstructured":"Barthel H, Villemagne VL, Drzezga A (2022) Future directions in molecular imaging of neurodegenerative disorders. J Nucl Med 63:68s\u201374s","journal-title":"J Nucl Med"},{"key":"11892_CR44","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00415-020-09806-3","volume":"267","author":"A Carotenuto","year":"2020","unstructured":"Carotenuto A, Wilson H, Giordano B et al (2020) Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications. J Neurol 267:2042\u20132053","journal-title":"J Neurol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11892-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11892-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11892-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:08:57Z","timestamp":1772446137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11892-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["11892"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11892-8","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Wenzhen Zhu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"X.Z. is affiliated with Philips Healthcare. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by the Institutional Review Board of Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology (ethical approval number: TJ-IRB20231102).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}